RankingsPricing
  1. US-listed companies
  2. Pediatrix Medical Group, Inc.

Pediatrix Medical Group, Inc.MD

Market cap
$913.34M
P/E ratio
Back to summarized table
Income statementBalance sheetCash flow
Dec 31,
2010		Dec 31,
2011		Dec 31,
2012		Dec 31,
2013		Dec 31,
2014		Dec 31,
2015		Dec 31,
2016		Dec 31,
2017		Dec 31,
2018		Dec 31,
2019		Dec 31,
2020		Dec 31,
2021		Dec 31,
2022
Net Income (loss)203218241281317336325320269-1,498-79613166
(Income) loss from discontinued operations----------348-787234
Depreciation and amortization2225314046648910311179283236
Amortization of Debt Issuance Costs and Discounts------5656742
Loss on early extinguishment of debt------------15-57
Stock-based compensation expense26272831323234303935391916
Deferred income taxes248211631418-60-24-17736-31-23
Gain on sale of building------------7-
Other-------411-002-0
Accounts receivable17491837575534-837-8-38736
Prepaid expenses and other current assets-430-0-251351048-42-16
Other long-term assets-------1030-38-14-10-17
Accounts payable and accrued expenses-3721174966-812251510448210
Income taxes receivable (payable)197-767-4-273-61-24-7-218
Payment of contingent consideration liabilities-------111-0-
Long-term professional liabilities---------410426
Other liabilities-02012-3-7-1-4-284-23-20
Net cash provided by operating activities – continuing operations----423369444511-338154114182
Cash Provided by (Used in) Operating Activities, Discontinued Operations---------851-37-15
Net cash provided by operating activities241271326405----29034720577167
Acquisition payments, net of cash acquired3391554412384798197625321141122-3028
Purchases of investments26433321273461281635621517
Proceeds from maturities or sales of investments16382811213241251451331617
Purchases of property and equipment12311416182739494932293230
Proceeds from sale of buildings-----------25-
Strategic investments------------20-
Other-----------11
Net cash (used in) provided by investing activities – continuing operations-----504-848-821-577-122-58-55-57
Net cash provided by investing activities - discontinued operations----------198742-
Net cash (used in) provided by investing activities-362-191-461-263-----143102816-53-57
Proceeds from Lines of Credit6845135189121,7552,1221,9402,8461,7241,247528-830
Payments on credit agreement5886304031,0291,2142,1561,5102,6992,0951,987528-826
Redemption of senior notes, including call premium-----------7601,047
Proceeds from issuance of senior notes-----750--500500--650
Payments on term loan------------9
Payments for credit facility amendment and financing costs----414-4791-9
Payments of contingent consideration liabilities-------5510-0-
Payments on finance lease obligations-----------33
Proceeds from issuance of common stock23312929432022231611775
Repurchases of common stock---5248823562703021458589
Proceeds from Noncontrolling Interests----1--1--0--
Other-----------19
Net cash used in financing activities – continuing operations----9848338290--393-3-760-488
Net cash used in financing activities – discontinued operations-----------1--
Net cash used in financing activities121-88138-132-----171-393-4-760-488
Net (decrease) increase in cash and cash equivalents---------23561,016-736-378
Interest-3237206074839511087116
Income taxes891191301261621811767518586-285527
Lease Obligation Incurred-1--1321--1370
Capital Expenditures Incurred but Not yet Paid-----23332223